((5R)-4-(5-CHLORO-2-BENZOXAZOLYL)HEXAHYDRO-5-METHYL-1H-1,4-DIAZEPIN-1-YL)(5-METHYL-2-(2H-1,2,3-TRIAZOL-2-YL)PHENYL)METHANONE
UNII C6G3CY8SCN
Substance Identification & Data
This profile provides standardized clinical and technical data for ((5r)-4-(5-chloro-2-benzoxazolyl)hexahydro-5-methyl-1h-1,4-diazepin-1-yl)(5-methyl-2-(2h-1,2,3-triazol-2-yl)phenyl)methanone, uniquely identified by the FDA Unique Ingredient Identifier (UNII) C6G3CY8SCN.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1276666-19-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C23H23ClN6O2 MDEQDBLHVPZJLQ-MRXNPFEDSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for ((5r)-4-(5-chloro-2-benzoxazolyl)hexahydro-5-methyl-1h-1,4-diazepin-1-yl)(5-methyl-2-(2h-1,2,3-triazol-2-yl)phenyl)methanone. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.